Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion

Journal of Clinical Microbiology

Volumn 41, Issue 12, 2003, Pages 5623-5632

  Hazen, Kevin C ^a,ca   Baron, Ellen Jo ^b   Colombo, Arnaldo Lopes ^c   Girmenia, Corrado ^d   Sanchez Sousa, Aurora ^e   Del Palacio, Amalia ^f   De Bedout, Catalina ^g,s   Gibbs, David L ^h   Tiraboschi, Nora ⁱ   Finquelievich, Jorge ^j   Ellis, David ^k   Frameree, Dominique ^l   Van Den Abeele, Anne Marie ^m   Rennie, Robert ^o   Sanche, Steve ^p   Bijie, Hu ^q   Xu, Yingchun ^r   Restrepo, Angela ^s   Vega, Ricardo ^t   Mendez, Matilde ^t   Mallatova, Nada ^u   Dobiasova, Stanislava ^v   Ayabaca, Julio ^w   Mallie, Michele ^x   Candolfi, E ^y   Sequela, J P ^z   Linas, M D ^z   Dupont, Bertrand ^aa   Braveny, I ^ab   Haase, G ^ac   Rodloff, Arne ^ad   Bar, W ^ae   Gobel, U ^af   Petrikos, George ^ag   Puskas, Erzsebet ^ah   Gyula, Mestyan ^ai   Erzsébet, Nagy ^aj   István, Barcs ^ak   Korhaz, Bajcsy ^ak   Konkoly Thege, M ^ak   Tullio, Vivian ^al   D'Antonio, Domenico ^am   Scalise, Giorgio ^an   Schito, G C ^ao   Fortina, G ^ap   Testore, Gian Piero ^aq   Eugenio, Ospedale S ^aq   Martino, Pietro ^aq   Lee, Kyung Won ^ar   Peng, Ng Kee ^as   Zaidi, Mussaret ^at   Alpuche, Celia ^au   Santos, Jose ^au   Meis, Jacques F G M ^av   Dzierzanowska, Danuta ^aw   Stratchounski, Leonid ^ax   Langsadl, Leon ^ay   Trupl, Jan ^az   Vaculikova, Alena ^ba   Helena, Hupkova ^bb   Roditi, Denise ^bc   Hoosen, Anwar ^bd   Van Rensburg, Janse ^be   Crewe Brown, Heather H ^bf   Towindo, Tiri ^bg   Garau, Margarita ^f   Alvarez, M Elena ^e   Bille, Jacques ^bh   Muhlethaler, K ^bi   Chang, Shan Chwen ^bj   Yu, Hkwok Woon ^bk   Wang, Jen Hsien ^bl   Tharavichitkul, Prasit ^bm   Vorachit, Chiang Mai Malai ^bn   Korten, Volkan ^bo   Gur, Deniz ^bp,bq   Weightman, Nigel ^br   Gould, Ian M ^br   Ashbee, Ruth ^bs   Larone, Davise ^bt   Jenkins, Stephen ^bu   Chaturvedi, Vishnu ^bv   Hindler, Janet ^bw   Rinaldi, Mike ^bx   Sobel, Jack ^by   Ghannoum, Mahmoud A ^bz   Santiago, Axel ⁿ   more..

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g Unidad de Biología Celular y Molecular   (Colombia)

^h Giles Scientific Inc   (United States)

ⁱ Hospital Escuela Gral   (Argentina)

^j UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^k WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^l Centre Hospitalier Universitaire de Charleroi   (Belgium)

^m St Lucas Campus Heilige Familie ^*  (Belgium)

ⁿ HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^o UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^p ROYAL UNIVERSITY HOSPITAL   (Canada)

^q ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^r PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^s Corporacionpara Investigaciones Biologicas ^*  (Colombia)

^t HOSPITAL MILITAR CENTRAL   (Colombia)

^u Hospital Ceske Budejovice   (Czech Republic)

^v Regional Institute of Hygiene   (Czech Republic)

^w AA HG1   (Ecuador)

^x UNIV MONTPELLIER   (France)

^y Institut de Parasitologie   (France)

^z CHU RANGUEIL   (France)

^aa INSTITUT PASTEUR   (France)

^ab TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ac RWTH AACHEN UNIVERSITY   (Germany)

^ad Inst fur Med Mikrobiol/Infekt   (Germany)

^ae Klinikum Carl Thiem   (Germany)

^af CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ag LAIKO GENERAL HOSPITAL   (Greece)

^ah ANTSZ BAZ Megyei Intezete   (Hungary)

^ai UNIVERSITY OF PÉCS   (Hungary)

^aj UNIVERSITY OF SZEGED   (Hungary)

^ak Public Health   (Hungary)

^al UNIVERSITY OF TURIN   (Italy)

^am Ospedale Civile di Pescara   (Italy)

^an Instituto di Malattie Infettive   (Italy)

^ao UNIVERSITY OF GENOA   (Italy)

^ap Ospedale Di Novara   (Italy)

^aq Dipartimento di Biotecnologie Cellulari ed Ematologia   (Italy)

^ar Yonsei University College of Medicine   (South Korea)

^as UNIVERSITY OF MALAYA   (Malaysia)

^at Hospital General O'Horan   (Mexico)

^au HOSPITAL GENERAL DE MÉXICO   (Mexico)

^av RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^aw CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^ax SMOLENSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^ay HOLY CROSS HOSPITAL   (United States)

^az National Cancer Center Hospital   (United States)

^ba Derer 's University Hospital Slovakia   (Slovakia)

^bb St Cyril and Method Hospital   (Slovakia)

^bc UNIVERSITY OF CAPE TOWN   (South Africa)

^bd SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^be Pelanomi Hospital   (South Africa)

^bf UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^bg UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^bh LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^bi UNIVERSITY OF BERN   (Switzerland)

^bj NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^bk VGH TPE   (Taiwan)

^bl CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^bm CHIANG MAI UNIVERSITY   (Thailand)

^bn MAHIDOL UNIVERSITY   (Thailand)

^bo MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^bp HACETTEPE UNIVERSITY   (Turkey)

^bq FRIARAGE HOSPITAL   (United Kingdom)

^br NHS GRAMPIAN   (United Kingdom)

^bs LEEDS GENERAL INFIRMARY   (United Kingdom)

^bt WEILL CORNELL MEDICAL CENTER   (United States)

^bu MOUNT SINAI MEDICAL CENTER   (United States)

^bv NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^bw UCLA MEDICAL CENTER   (United States)

^bx UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^by WAYNE STATE UNIVERSITY   (United States)

^bz UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^ca UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOTYPE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COMPUTER PROGRAM; DATA ANALYSIS; DIFFUSION; DISK DIFFUSION METHOD; DRUG RESPONSE; E-MAIL; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; IMAGE ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; UPPER RESPIRATORY TRACT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI;

EID: 0346218270     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.12.5623-5632.2003     Document Type: Article

References (24)

1. Barry, A., and S. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.
2. Bille, J., and M. P. Glauser. 1997. Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 16:924-928.
3. Chryssanthou, E., and M. Cuenca-Estrella. 2002. Comparison of the Anti-fungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J. Clin. Microbiol. 40:3841-3844.
4. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
5. Florea, N. R., J. L. Kuti, and R. Quintiliani. 2002, Voriconazole: a novel azole antifungal. Formulary 37:387-398.
6. Grant, S. M., and S. P. Clissold. 1990. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential insuperficial and systemic mycoses. Drugs 39(6):877-916.
7. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
8. Kaufman, D., R. Boyle, K. C. Hazen, J. T. Patrie, M. Robinson, and L. G. Donowitz. 2001. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345:1660-1666.
9. Liebowitz, L. D., H. R. Ashbee, E. G. V. Evans, Y. Chong, N. Mallatova, M. Zaidi, D. Gibbs, and G. A. S. Group. 2001. A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 40:27-33.
10. Lozano-Chiu, M., S. Arikan, V. L. Paetznick, E. J. Anaissie, and J. H. Rex. 1999. Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility. J. Clin Microbiol. 37:2755-2759.
11. Marr, K. A., K. Seidel, T. C. White, and R. A. Bowden. 2000. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J. Infect. Dis. 181:309-316.
12. Meis, J. F. G. M., M. Petrou, J. Bille, D. Ellis, D. Gibbs, and The Global Antifungal Surveillance Group. 2000. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 36:215-223.
13. NCCLS. 1999. Performance standards for antimicrobial susceptibility testing; ninth supplement to the M2-A6, M100-S9. NCCLS, Villanova, Pa.
14. NCCLS. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A. NCCLS, Wayne, Pa.
15. Nho, S., M. J. Anderson, C. B. Moore, and D. W. Denning. 1997. Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains. J. Clin, Microbiol. 35:1036-1039.
16. Pfaller, M. A., D. J. Diekema, L. Boyken, S. A. Messer, S. Tendolkar, and R. J. Hollis. 2003. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J. Clin. Microbiol. 41:1875-1880.
17. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.
18. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:78-83.
19. Pfaller, M. A., S. A. Messer, R. J. Hollis, R. N. Jones, and D. J. Diekema. 2002. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 46:1723-1727.
20. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
21. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
22. Saiman, L., E. Ludington, M. A. Pfaller, S. Rangel-Frausto, R. T. Wiblin, J. Dawson, H. M. Blumberg, J. E. Patterson, M. G. Rinaldi, J. E. Edwards, R. P. Wenzel, W. Jarvis, and The National Epidemiology of Mycosis Survey Study Group. 2000. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 19:319-324.
23. Sobel, J. D. 1993. Genital candidiasis, p. 225-247. In G. P. Bodey (ed.), Candidiasis: pathogenesis, diagnosis, and treatment, 2nd ed. Raven Press, New York, N.Y.
24. Vanden Bossche, H., F. Dromer, I. Improvisi, M. Lozano-Chiu, J. H. Rex, and D. Sanglard. 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36(Suppl. 1):119-128.